Cumberland pulls lots of particulate-plagued liver drug

Just as the year marches to its inevitable end, we have yet another particle-related recall to add to 2010's tally. Cumberland Pharmaceuticals is pulling six lots of its injectable liver drug, Acetadote, because some vials contained fine particles. The recall is precautionary rather than prompted by adverse-event reports.

Cumberland says the particles' source was the glass vial used by a former packaging supplier. And the company is far from the only one to suffer recently from tiny glass flakes or particles in injectable products. Other sorts of particles have plagued drugmakers from Johnson & Johnson to Amgen.

- read the Reuters news

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.